Successful treatment with hydrogen rich water in a case of chronic graft-versus-host-disease.
水素豊富水摂取による慢性移植片対宿主病の1症例報告
Abstract
Chronic graft-versus-host disease (cGVHD) is a serious complication following allogeneic hematopoietic stem cell transplantation, with inflammation and fibrosis identified as central pathogenic mechanisms. Molecular hydrogen possesses anti-inflammatory, antioxidant, and anti-fibrotic properties, suggesting potential relevance to cGVHD pathophysiology. This case report describes a patient with severe cGVHD who consumed hydrogen-rich water and experienced notable clinical improvement. The authors propose that oral intake of hydrogen-rich water may represent a safe and potentially beneficial approach for managing this difficult condition, warranting further investigation in controlled settings.
Mechanism
Molecular hydrogen's anti-inflammatory, antioxidant, and anti-fibrotic properties may suppress the inflammation and fibrosis that underlie cGVHD pathogenesis.
Bibliographic
- Authors
- Qian L, Shen J
- Journal
- Med Gas Res
- Year
- 2016
- PMID
- 27867488
- DOI
- 10.4103/2045-9912.191366
- PMC
- PMC5110137
Tags
Delivery context
Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).
Safety notes
See also: